Related Topics News -

     
 Detail   |   Print    Next page > 
     
康臣葯業午後曾抽高14%成交配合 上半年純利升19.5%增派息
2026-08-26T  
《業績》康臣葯業中期純利5.95億人民幣升19.5% 派息0.38港元
2026-08-26T  
康臣葯業斥約1.91億人幣收購上海華茂藥業30%股權
2026-06-08T  
《業績》康臣葯業全年純利10.78億元人民幣升18.4% 派末期息0.4港元
2026-03-26T  
《大行》招商證券升康臣藥業目標價至15.9元 估值低且股息收益率吸引
2025-08-29T  
康臣葯業漲逾6%創新高 中期多賺24.6%增派息
2025-08-19T  
《業績》康臣葯業半年純利4.98億元人民幣升24.6% 派中期息33港仙
2025-08-19T  
康臣葯業計劃股份回購 資金最多2億元
2025-06-15T  
康臣葯業益腎化濕顆粒獲批中藥二級保護品種
2025-04-30T  
康臣葯業治療腎臟疾病藥物於中國獲批開展臨床試驗
2025-04-25T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.